Adjuvant Hormonotherapy (Tamoxifen Versus Medro-Xyprogesterone Acetate Versus Control) in Women With Endometrial Cancer, Figo Stage I and II

Journal of Cancer Research and Clinical Oncology - Germany
doi 10.1007/bf02580300
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search